LOGISTICS PROCESS OF PHARMACY COMPANIES.

MEMBERS

AKSHAY SURVE

Introduction Logistics is the management of the flow of resources

 between the point of origin and the point of consumption in order to meet some requirements.

For example, of customers or corporations. The resources managed in logistics can include physical items, such as food, materials, equipment, liquids, and staff, as well as abstract items, such as time, information, particles, and energy.

DefinitionDefinitionThe task of coordinating material flow and information flow across the supply chain.

LOGISTICS PROCESS

The Supply Chain management

A supply chain is a group of partners who collectively convert a basic commodity (upstream) into a finished product (downstream) that is valued by end-customers, and who manage returns at each stage.

DefinitionDefinitionPlanning and controlling all of the processes that link partners in a supply chain together in order to serve needs of the end-customer.

PHARMACY

Pharmacy is the science and technique of preparing and dispensing drugs and medicines. It is a health profession that links the health sciences with the chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs.

Various Pharmaceutical Companies

CIPLACipla Limited is a 

pharmaceutical company based in Mumbai, India. Founded by nationalist Indian scientist Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories in 1935, Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions.

Logistics Process Of CIPLA

MANUFACTURING

PROCUREMENT

OUTPUT/ FINISHED GOODS

WAREHOUSING

TRANSPORTATION

DISTRIBUTION

LABORATORIES RETAILERS

CUSTOMERS

MEDICAL STORES

13

Supplier Materials Biologic suppliers

◦ Chemicals◦ Farm products (plants, eggs, animals, animal by-products)◦ Laboratory animals◦ Growth media, cell cultures◦ Pathogens◦ Proteins◦ Test organisms

Non-biologic suppliers

◦ Equipment◦ Computers, software◦ Databases (e.g., target molecules, DNA sequences)◦ Clinical trial supplies◦ Clinical trial subject population information

14

Make - Manufacturing (Commercialization) SCM Strategies

Standardization of manufacturing processes◦ Terminology◦ Metrics◦ Product process “toolkits”

Managing network assets◦ Grouping plants with standard equipment and

processes geared to specific product types (e.g., dry products, freeze-dried, parenteral)

◦ Redundant facilities (security, shifting of work between plants)

Improved demand forecasting◦ Global demand management center◦ Centralized ownership of all forecasting tools and

databases◦ Use of ERP web-enabled global planning capabilities

Judicious use of contract manufacturing (e.g., packaging)

WAREHOUSING

Cipla uses the latest in pharmaceutical technology to funnel seven decades of experiences into one capsule that cures, one drop that defends and one puff that protects. They explore every drug to its last particle and instill safe

and sure healing to create one dose of confidence. 

16

Distribute – Types of Counterfeit Drugs

Identical copies◦ Least common◦ Made with same ingredients, formulas and

packaging but not by the same manufacturer Look-alikes:

◦ High-quality packaging and labeling; very convincing appearance

◦ Little or no active ingredients Re-labels:

◦ Authentic drugs that have passed their expiration dates

◦ Distributed by foreign sources.

17

Pharmacy Group Purchasing Organizations (GPOs)◦ Alliances of pharmacies, hospitals and other healthcare systems ◦ Leverage buying power to obtain manufacturer discounts

Often turn to secondary distribution channels when manufacturers or major distributors cannot supply critical drugs when needed

◦ Drugs often stockpiled by secondary distributors for economic reasons

◦ Drug markups can be 500 – 1,000% during shortages (e.g., a vial of flu vaccine purchased by a wholesaler for $23.65 was resold to an end-user for $147 in 2003)

Temperature-sensitive products, when diverted, are often not kept at the appropriate temperatures

Retailers attribute 48 percent of pharmaceutical inventory loss to employee theft

Emerging requirements for secondary distributors to provide a drug pedigree that can be tracked back to the original source (manufacturer)

◦ Clear “chain of custody”◦ Cost of maintaining custodial information will fall on manufacturers

Buy – The Retailers

CONCLUSION

THANKYOU